Replication and Propagation of Attenuated Vesicular Stomatitis Virus Vectors In Vivo: Vector Spread Correlates with Induction of Immune Responses and Persistence of Genomic RNA
- 15 February 2007
- journal article
- research article
- Published by American Society for Microbiology in Journal of Virology
- Vol. 81 (4) , 2078-2082
- https://doi.org/10.1128/jvi.02525-06
Abstract
Live-attenuated vesicular stomatitis virus (VSV) vectors expressing foreign antigens induce potent immune responses and protect against viral diseases in animal models. Highly attenuated (VSV-CT1) or single-cycle VSV (VSVΔG) vectors induce immune responses lower than those generated by attenuated wild-type VSV vectors when given intranasally. We show here that reduced spread of the more highly attenuated or single-cycle vectors to other organs, including lymph nodes, correlates with the reduction in the immune responses. A reverse transcription, real-time PCR assay for VSV genomic RNA (gRNA) sequences showed long-term persistence of gRNA from replicating vectors in lymph nodes, long after viral clearance. Such persistence may be important for induction of potent immune responses by VSV vectors.Keywords
This publication has 20 references indexed in Scilit:
- Persistent Antigen Presentation after Acute Vesicular Stomatitis Virus InfectionJournal of Virology, 2007
- Immunogenicity of Attenuated Vesicular Stomatitis Virus Vectors Expressing HIV Type 1 Env and SIV Gag Proteins: Comparison of Intranasal and Intramuscular Vaccination RoutesAIDS Research and Human Retroviruses, 2004
- Characterization of Nonpathogenic, Live, Viral Vaccine Vectors Inducing Potent Cellular Immune ResponsesJournal of Virology, 2004
- Complete Protection from Papillomavirus Challenge after a Single Vaccination with a Vesicular Stomatitis Virus Vector Expressing High Levels of L1 ProteinJournal of Virology, 2004
- Successful mucosal immunization of cotton rats in the presence of measles virus-specific antibodies depends on degree of attenuation of vaccine vector and virus doseJournal of General Virology, 2003
- Intranasal Vaccination with a Recombinant Vesicular Stomatitis Virus Expressing Cottontail Rabbit Papillomavirus L1 Protein Provides Complete Protection against Papillomavirus-Induced DiseaseJournal of Virology, 2002
- Relative Neurotropism of a Recombinant Rhabdovirus Expressing a Green Fluorescent Envelope GlycoproteinJournal of Virology, 2002
- Replication-Competent or Attenuated, Nonpropagating Vesicular Stomatitis Viruses Expressing Respiratory Syncytial Virus (RSV) Antigens Protect Mice against RSV ChallengeJournal of Virology, 2001
- An Effective AIDS Vaccine Based on Live Attenuated Vesicular Stomatitis Virus RecombinantsCell, 2001
- Construction of a Novel Virus That Targets HIV-1-Infected Cells and Controls HIV-1 InfectionCell, 1997